AST 2x ALT in Alcoholic Liver Disease
An AST/ALT ratio greater than 2 is highly suggestive of alcoholic liver disease, particularly alcoholic hepatitis, and this pattern is present in approximately 70% of patients with ALD. 1
Understanding the AST/ALT Ratio Pattern
The AST/ALT ratio serves as a useful biochemical marker to distinguish alcoholic liver disease from other causes of hepatocellular injury:
Key Diagnostic Thresholds
- AST/ALT ratio >2: Typically seen in alcoholic hepatitis and is present in about 70% of ALD patients 1
- AST/ALT ratio >3: Highly suggestive of alcoholic liver disease with even greater specificity 1
- AST/ALT ratio <1: More characteristic of non-alcoholic fatty liver disease (NAFLD), where the ratio averages 0.9 2
The most recent ACR guidelines (2023) specifically state that the AST:ALT ratio is generally >2 in alcohol-induced fatty liver disease and <1 in metabolic disease-related fatty liver. 2
Why This Pattern Occurs
The predominance of AST over ALT in alcoholic liver disease reflects several pathophysiologic mechanisms:
- AST is present in both mitochondria and cytoplasm, while ALT is primarily cytoplasmic
- Alcohol causes mitochondrial damage, releasing mitochondrial AST
- Chronic alcohol use depletes pyridoxal-5'-phosphate (vitamin B6), a cofactor needed for ALT synthesis, leading to relatively lower ALT levels
- The absolute levels typically show AST elevated 2-6 times the upper limit of normal, while both enzymes rarely exceed 300-400 IU/L 1, 3
Clinical Application and Limitations
When the Ratio is Most Reliable
The AST/ALT ratio >2 has greater diagnostic value in patients without cirrhosis 1. In established cirrhosis from any cause, the ratio may become less specific as the pattern can shift.
Important Caveats
The ratio is not 100% sensitive: Approximately 30% of patients with alcoholic hepatitis may have an AST/ALT ratio ≤2 4
Absolute enzyme levels matter: AST levels >500 IU/L or ALT >200 IU/L are uncommon in pure alcoholic hepatitis and should prompt consideration of alternative or concurrent diagnoses such as:
The ratio increases with disease severity: In NASH/NAFLD, the AST/ALT ratio progressively increases from 0.7 (no fibrosis) to 0.9 (mild fibrosis) to 1.4 (cirrhosis), potentially causing diagnostic confusion in advanced disease 5
Non-hepatic causes of elevated AST: If AST is disproportionately elevated, consider hemolysis, myopathy, thyroid disease, or strenuous exercise 2
Diagnostic Algorithm
To use the AST/ALT ratio effectively:
Obtain detailed alcohol history: Daily consumption >40g in men or >20g in women for >6 months 4, 3
Check the AST/ALT ratio:
- Ratio >2 with appropriate alcohol history → strongly suggests ALD
- Ratio >3 → highly specific for ALD
- Ratio <1 → consider NAFLD or other causes
Verify absolute enzyme levels:
- Both typically <300-400 IU/L in pure ALD
- Higher levels warrant investigation for alternative diagnoses
Look for supporting laboratory findings 4:
- Elevated GGT (75% of heavy drinkers)
- Elevated MCV (macrocytosis)
- Thrombocytopenia
- Leukocytosis (in alcoholic hepatitis)
- Hyperbilirubinemia (in alcoholic hepatitis)
Consider liver biopsy when:
- Diagnosis remains uncertain despite clinical and laboratory evaluation
- Severe alcoholic hepatitis requiring corticosteroid therapy (to confirm diagnosis and assess prognosis) 4
- Atypical features suggest alternative or concurrent liver disease
Distinguishing ALD from NAFLD
The AST/ALT ratio is particularly valuable for differentiating alcoholic from non-alcoholic steatohepatitis 5:
- NAFLD/NASH: Mean ratio 0.9 (range 0.3-2.8), with ALT typically higher than AST
- ALD: Mean ratio 2.6 (range 1.1-11.2), with AST typically higher than ALT
- A ratio ≥2 is strongly suggestive of alcoholic liver disease with high specificity 5
Bottom Line for Clinical Practice
While an AST/ALT ratio >2 is a useful and readily available marker that supports the diagnosis of alcoholic liver disease, it should never be used in isolation. The diagnosis of ALD requires integration of alcohol consumption history, clinical presentation, exclusion of other liver diseases, and supporting laboratory abnormalities. The ratio performs best when both the clinical context is appropriate and absolute aminotransferase levels are consistent with ALD (typically <300-400 IU/L). 2, 1, 3